|
1
|
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
|
Science
|
1999
|
7.66
|
|
2
|
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
|
Science
|
1997
|
5.55
|
|
3
|
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.
|
Nat Med
|
1998
|
5.08
|
|
4
|
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).
|
J Infect Dis
|
1995
|
4.60
|
|
5
|
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
|
Arch Intern Med
|
2001
|
3.74
|
|
6
|
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
|
N Engl J Med
|
1990
|
3.61
|
|
7
|
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
|
J Clin Invest
|
1988
|
3.59
|
|
8
|
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
|
Br Med J (Clin Res Ed)
|
1986
|
3.27
|
|
9
|
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
|
Br Med J (Clin Res Ed)
|
1986
|
2.75
|
|
10
|
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.
|
Proc Natl Acad Sci U S A
|
1998
|
2.39
|
|
11
|
Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.
|
AIDS
|
1998
|
2.19
|
|
12
|
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
|
AIDS
|
2000
|
2.14
|
|
13
|
The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study.
|
AIDS
|
1992
|
2.06
|
|
14
|
[Therapeutic options for HIV infection should lead to increased utilization of HIV tests].
|
Ned Tijdschr Geneeskd
|
1999
|
2.01
|
|
15
|
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus.
|
Clin Infect Dis
|
1997
|
1.80
|
|
16
|
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
|
JAMA
|
1996
|
1.77
|
|
17
|
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2000
|
1.68
|
|
18
|
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs.
|
AIDS
|
1999
|
1.64
|
|
19
|
Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
|
Br J Ophthalmol
|
1998
|
1.57
|
|
20
|
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
|
AIDS
|
2000
|
1.56
|
|
21
|
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.
|
BMJ
|
1989
|
1.39
|
|
22
|
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97].
|
Ned Tijdschr Geneeskd
|
1998
|
1.39
|
|
23
|
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.
|
J Infect Dis
|
1999
|
1.32
|
|
24
|
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
|
AIDS
|
1987
|
1.32
|
|
25
|
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.
|
J Infect Dis
|
1999
|
1.28
|
|
26
|
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.
|
AIDS Res Hum Retroviruses
|
2001
|
1.22
|
|
27
|
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
|
AIDS
|
1998
|
1.21
|
|
28
|
A context-learning pharmacotherapy program for preclinical medical students leads to more rational drug prescribing during their clinical clerkship in internal medicine.
|
Clin Pharmacol Ther
|
2008
|
1.21
|
|
29
|
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy.
|
Proc Natl Acad Sci U S A
|
2000
|
1.20
|
|
30
|
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
|
AIDS
|
1998
|
1.20
|
|
31
|
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.
|
AIDS
|
2001
|
1.18
|
|
32
|
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group.
|
AIDS
|
2000
|
1.18
|
|
33
|
Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
|
Lancet
|
1988
|
1.17
|
|
34
|
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection.
|
Proc Natl Acad Sci U S A
|
1999
|
1.16
|
|
35
|
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.
|
AIDS
|
2000
|
1.16
|
|
36
|
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
|
J Infect Dis
|
1999
|
1.13
|
|
37
|
QUOTE-HIV: an instrument for assessing quality of HIV care from the patients' perspective.
|
Qual Saf Health Care
|
2003
|
1.12
|
|
38
|
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.
|
Proc Natl Acad Sci U S A
|
1999
|
1.08
|
|
39
|
Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
|
Genitourin Med
|
1990
|
1.04
|
|
40
|
Foscarnet and penile ulceration.
|
Lancet
|
1990
|
1.04
|
|
41
|
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection.
|
Immunol Lett
|
1999
|
1.02
|
|
42
|
Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection.
|
AIDS
|
2001
|
1.01
|
|
43
|
Serological and polymerase chain reaction-based analysis of aqueous humour samples in patients with AIDS and necrotizing retinitis.
|
AIDS
|
1996
|
1.01
|
|
44
|
Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group.
|
Clin Infect Dis
|
2000
|
1.00
|
|
45
|
Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals.
|
J Acquir Immune Defic Syndr
|
1990
|
0.99
|
|
46
|
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy.
|
J Virol Methods
|
1987
|
0.99
|
|
47
|
Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection.
|
Br J Haematol
|
1987
|
0.99
|
|
48
|
Echocardiographic dimensions and maximal oxygen uptake in oarsmen during training.
|
Br Heart J
|
1981
|
0.95
|
|
49
|
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.
|
J Infect Dis
|
1997
|
0.95
|
|
50
|
Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosa.
|
AIDS
|
1995
|
0.92
|
|
51
|
Glomerular lesions and opportunistic infections of the kidney in AIDS: an autopsy study of 47 cases.
|
Adv Exp Med Biol
|
1989
|
0.92
|
|
52
|
Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases.
|
Int J STD AIDS
|
2000
|
0.92
|
|
53
|
Resumption of HIV antigen production during continuous zidovudine treatment.
|
Lancet
|
1988
|
0.91
|
|
54
|
Anorectal surgery in human immunodeficiency virus-infected patients. Clinical outcome in relation to immune status.
|
Dis Colon Rectum
|
1995
|
0.90
|
|
55
|
Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy.
|
AIDS
|
1998
|
0.88
|
|
56
|
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.
|
Arch Intern Med
|
1988
|
0.88
|
|
57
|
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.
|
J Acquir Immune Defic Syndr Hum Retrovirol
|
1997
|
0.88
|
|
58
|
Mycobacterium xenopi in HIV-infected patients: an emerging pathogen.
|
AIDS
|
1998
|
0.87
|
|
59
|
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
|
AIDS
|
2000
|
0.87
|
|
60
|
Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
|
AIDS Res Hum Retroviruses
|
2001
|
0.86
|
|
61
|
Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus.
|
Neth J Med
|
1989
|
0.86
|
|
62
|
Otorhinolaryngological findings in AIDS patients: a study of 63 cases.
|
Arch Otorhinolaryngol
|
1987
|
0.86
|
|
63
|
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.
|
AIDS Res Hum Retroviruses
|
2000
|
0.86
|
|
64
|
Local excision and mucosal advancement for anorectal ulceration in patients infected with human immunodeficiency virus.
|
Br J Surg
|
1995
|
0.86
|
|
65
|
HIV seropositivity and tuberculosis in a large general hospital in Malawi.
|
Trop Geogr Med
|
1990
|
0.85
|
|
66
|
Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.
|
AIDS Res Hum Retroviruses
|
1989
|
0.84
|
|
67
|
Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir.
|
AIDS
|
2000
|
0.83
|
|
68
|
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
|
AIDS
|
1988
|
0.82
|
|
69
|
[The acquired immunodeficiency syndrome (AIDS)].
|
Ned Tijdschr Geneeskd
|
1983
|
0.81
|
|
70
|
Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.
|
Antivir Ther
|
1997
|
0.81
|
|
71
|
Common health problems in HIV-infected travelers to the (sub)tropics.
|
J Travel Med
|
1999
|
0.81
|
|
72
|
HIV infection and squamous cell carcinoma of sun-exposed skin.
|
AIDS
|
1990
|
0.81
|
|
73
|
AIDS dementia complex and didanosine.
|
Lancet
|
1994
|
0.80
|
|
74
|
Determination of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in biological fluids by reverse-phase high pressure liquid chromatography.
|
Pharm Weekbl Sci
|
1987
|
0.80
|
|
75
|
No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.
|
Clin Infect Dis
|
2001
|
0.80
|
|
76
|
Antiretroviral treatment: state of the art and future directions.
|
AIDS
|
1991
|
0.80
|
|
77
|
Amprolium for coccidiosis in AIDS.
|
Lancet
|
1984
|
0.80
|
|
78
|
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy.
|
Blood
|
2000
|
0.80
|
|
79
|
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.
|
Antiviral Res
|
1998
|
0.80
|
|
80
|
Prediction of infarct size from serial CK determinations: evaluation by clinical studies and computer simulation.
|
Clin Chim Acta
|
1979
|
0.80
|
|
81
|
Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients.
|
AIDS Care
|
1998
|
0.79
|
|
82
|
General operative aspects of human immunodeficiency virus infection and acquired immunodeficiency syndrome.
|
J Am Coll Surg
|
1995
|
0.79
|
|
83
|
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
|
J Clin Invest
|
1997
|
0.79
|
|
84
|
Biochemical and circulatory parameters during purely mental stress.
|
Acta Med Scand
|
1981
|
0.79
|
|
85
|
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
|
HIV Med
|
2006
|
0.79
|
|
86
|
Ocular and neurological complications of varicella zoster virus infection in a patient with AIDS.
|
AIDS
|
1996
|
0.78
|
|
87
|
Acquired immune deficiency syndrome, altered T cell subset ratios, and cytomegalovirus infections among male homosexuals in The Netherlands.
|
Antibiot Chemother (1971)
|
1983
|
0.78
|
|
88
|
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy.
|
AIDS
|
2001
|
0.78
|
|
89
|
Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS.
|
AIDS
|
1991
|
0.77
|
|
90
|
[CBO guidelines 'Antiretroviral therapy in the Netherlands'].
|
Ned Tijdschr Geneeskd
|
2001
|
0.77
|
|
91
|
Macronodular adrenocortical hyperplasia in a postmenopausal woman.
|
Neth J Med
|
2004
|
0.77
|
|
92
|
Can the course of high dose cotrimoxazole for Pneumocystis carinii pneumonia in AIDS be shorter? A possible solution to the problem of cotrimoxazole toxicity.
|
J Intern Med
|
1990
|
0.77
|
|
93
|
[Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
|
Ned Tijdschr Geneeskd
|
1990
|
0.76
|
|
94
|
Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patients.
|
J Acquir Immune Defic Syndr Hum Retrovirol
|
1996
|
0.76
|
|
95
|
Implantation of cultured thymic fragments in patients with acquired immunodeficiency syndrome.
|
Arch Intern Med
|
1986
|
0.76
|
|
96
|
Fansidar and Pneumocystis carinii pneumonia.
|
Ann Intern Med
|
1988
|
0.76
|
|
97
|
Continued zidovudine and interferon-alpha therapy in Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
|
Ann Intern Med
|
1990
|
0.75
|
|
98
|
Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitro.
|
Clin Exp Immunol
|
1986
|
0.75
|
|
99
|
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
|
Ann Intern Med
|
1995
|
0.75
|
|
100
|
The Concorde trial.
|
Lancet
|
1993
|
0.75
|
|
101
|
Cardiovascular health in the tenth decade.
|
Br Med J
|
1978
|
0.75
|
|
102
|
[AIDS and dentistry. Introduction to terminology].
|
Ned Tijdschr Tandheelkd
|
1987
|
0.75
|
|
103
|
Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma.
|
AIDS
|
1989
|
0.75
|
|
104
|
Effect of physical exercise on blood lipids and adipose tissue composition in young healthy men.
|
Atherosclerosis
|
1984
|
0.75
|
|
105
|
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
|
Eur J Cancer
|
1995
|
0.75
|
|
106
|
[Changed criteria in the diagnosis of AIDS].
|
Ned Tijdschr Geneeskd
|
1988
|
0.75
|
|
107
|
[Generalized histoplasmosis in 3 patients with an HIV infection].
|
Ned Tijdschr Geneeskd
|
1990
|
0.75
|
|
108
|
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
|
Ned Tijdschr Geneeskd
|
2001
|
0.75
|
|
109
|
Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment.
|
Antivir Ther
|
1996
|
0.75
|
|
110
|
Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcoma.
|
Int J STD AIDS
|
1990
|
0.75
|
|
111
|
Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir.
|
AIDS
|
1990
|
0.75
|
|
112
|
[HIV and dentistry. Part 3. HIV infection: pathogenesis, epidemiology, definitions and classification].
|
Ned Tijdschr Tandheelkd
|
1994
|
0.75
|
|
113
|
[Bacterial endocarditis in drug users].
|
Ned Tijdschr Geneeskd
|
1981
|
0.75
|
|
114
|
Reduction of myocardial infarct size by early intervention.
|
Neth J Med
|
1977
|
0.75
|
|
115
|
AIDS in The Netherlands. Clinical and microbiological data on 36 cases.
|
Neth J Med
|
1985
|
0.75
|
|
116
|
[Does latent HIV-infection exist?].
|
Ned Tijdschr Geneeskd
|
1994
|
0.75
|
|
117
|
[AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
|
Ned Tijdschr Geneeskd
|
1998
|
0.75
|
|
118
|
Gallium-67 lung scintigraphy in patients with acquired immune deficiency syndrome (AIDS).
|
Eur J Respir Dis
|
1986
|
0.75
|
|
119
|
[AIDS and tuberculosis; a retrospective study in 225 patients with AIDS].
|
Ned Tijdschr Geneeskd
|
1989
|
0.75
|
|
120
|
[Pneumocystis carinii pneumonia in patients with AIDS].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
121
|
[AIDS: a clinical diagnosis, hence one with pitfalls].
|
Ned Tijdschr Geneeskd
|
1985
|
0.75
|
|
122
|
[Tuberculosis: not a 'conquered' disease].
|
TVZ
|
1993
|
0.75
|
|
123
|
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
|
Antivir Ther
|
2001
|
0.75
|
|
124
|
[Disease symptoms and clinical course in the first 100 patients with AIDS].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
125
|
AIDS and tuberculosis. Results of a retrospective study in 225 AIDS patients.
|
Bull Int Union Tuberc Lung Dis
|
1990
|
0.75
|
|
126
|
Serodiagnostic profiles of HIV and HIV pathogenesis in vivo.
|
Haematologia (Budap)
|
1988
|
0.75
|
|
127
|
Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma.
|
J Intern Med
|
1991
|
0.75
|
|
128
|
[Medical dilemma of AIDS].
|
Ned Tijdschr Tandheelkd
|
1987
|
0.75
|
|
129
|
Additive or sequential nucleoside analogue therapy compared with continued zidovudine monotherapy in human immunodeficiency virus-infected patients with advanced disease does not prolong survival: an observational study.
|
J Infect Dis
|
1997
|
0.75
|
|
130
|
[Acquired immunodeficiency syndrome (AIDS) in Africa].
|
Ned Tijdschr Geneeskd
|
1985
|
0.75
|
|
131
|
[AIDS and dentistry. History, general diagnosis and medical care--an overview].
|
Ned Tijdschr Tandheelkd
|
1987
|
0.75
|
|
132
|
Attitudes of health-care workers towards AIDS at three Dutch hospitals.
|
AIDS
|
1991
|
0.75
|
|
133
|
[Interim advice from the Public Health Council concerning patients with acquired immunodeficiency syndrome].
|
Ned Tijdschr Geneeskd
|
1984
|
0.75
|
|
134
|
Severe complications of perianal sepsis in patients with human immunodeficiency virus.
|
Br J Surg
|
1996
|
0.75
|
|
135
|
Etoposide for epidemic Kaposi's sarcoma: a phase II study.
|
Eur J Cancer Clin Oncol
|
1988
|
0.75
|
|
136
|
Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
|
Br J Haematol
|
1991
|
0.75
|